Question 1

What is the catalog number for SBI-477?

Accepted Answer

The catalog number for SBI-477 is M22929.

Question 2

What sizes are available for SBI-477?

Accepted Answer

SBI-477 is available in the following size(s): 1 g, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg, 500 mg.

Question 3

How many pack sizes does SBI-477 come in?

Accepted Answer

SBI-477 is available in 7 different pack sizes.

Question 4

Is SBI-477 in stock?

Accepted Answer

SBI-477 is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

What is SBI-477 used for?

Accepted Answer

SBI-477 is a chemical probe stimulated insulin signaling by deactivating the transcription factor MondoA. SBI-477 coordinately inhibits triacylglyceride (TAG) synthesis and enhances basal glucose uptake in human skeletal myocytes.

Question 6

Does this cell line or biologic require a Material Transfer Agreement (MTA)?

Accepted Answer

Some products, including certain cell lines, plasmids, and tissue cultures, are subject to intellectual property terms and may require an MTA before we can ship. We’ll inform you in advance if this product requires one, and additional handling fees may apply.

Question 7

What should I do if I need to report a performance issue with a specific lot of this product?

Accepted Answer

Provide the catalogue number, product name, lot number, and your experimental results to our technical support team. They’ll investigate and, if needed, escalate to the manufacturer, provided the product was used before expiry and stored correctly.

Question 8

What is the isotype of this antibody?

Accepted Answer

Isotype information such as IgG1 or IgG2a is listed in the product specifications on the datasheet, relevant for selecting compatible detection reagents.

SBI-477

Product Specifications

CAS Number

Stability

Purity

Weight

Molecular Formula

Notes

Receptor

Available Sizes

Frequently Asked Questions

Explore Other Products

SWAP70 Antibody (FITC)

SWAP70 Antibody (FITC)

InVivoMAb Anti-Human CNR1/CB1 Nanobody (6B7)

InVivoMAb Anti-Human CNR1/CB1 Nanobody (6B7)

InVivoMAb Anti-Human CNR1/CB1 Nanobody (6B7)

PSMD2